Full Text View
Tabular View
No Study Results Posted
Related Studies
Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease (PD+)
This study is currently recruiting participants.
Verified December 2012 by Men's Health Boston
Study NCT01578473   Information provided by Men's Health Boston

First Received on April 12, 2012.   Last Updated on December 17, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Peyronie's Disease
Additional conditions recognized in this trial
Penile Induration
More general conditions related to this trial
Connective Tissue Diseases
Genital Diseases, Male
Penile Diseases
Interventions listed in this trial
Vitamin D2
Vitamin E
Testosterone Pellets
Additional drug interventions recognized in this trial
Ergocalciferols
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
Vitamin D
Vitamins
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Bone Density Conservation Agents
Growth Substances
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Men's Health Boston


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services